Delivery Order SPE2DB22D2206-SPE2DB24FEW58
Award Date 1/2/24
Potential Completion Date 1/3/24
Potential Value $9.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,156.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for LUMASON 25 milligram vials, with an ultimate completion date of January 29, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,450.40 by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Lumason 25 mg vials. The contract is firm fixed-price with no set-aside designation, indicating competitive award based on open competition. Performance is scheduled for completion by January 28, 2026, at the contractor's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,949.88 on December 31, 2025, for the supply of LUMASON 25 mg vials, with completion scheduled for January 2, 2026. This is a firm fixed price contract with no set-aside designation, executed through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,740.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, with an ultimate completion date of January 7, 2026. This non-set-aside contract was competitively awarded on January 6, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying critical...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,150,418 units of the drug LUMASON 25 MG VIALS. The $1,496.50 firm fixed price contract has an ultimate completion date of October 21, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,304.62 by the Defense Logistics Agency (DLA) on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract involves the delivery of Lumason 25 mg vials and is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement action under DLA's broader...
- The Defense Logistics Agency issued a $1,156.12 delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Lumason 25 mg vials. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price and ultimate completion date of March...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of LUNSUMIO 1 MG/ML Vialml, a pharmaceutical product, with a potential value of $1,808.91. The contract is a firm fixed price delivery order with a completion date of February 1, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp has a history of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution services company. The order is for OPTISON VIAL 3ML, a pharmaceutical product, with a potential value of $2,149.36 and a completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA to provide a comprehensive range of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,782.20 by the Defense Logistics Agency on January 22, 2026, for the supply of Gadavist 10 mmol/10 mL vials. This firm fixed-price delivery order is not set aside and is expected to be completed by January 23, 2026. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...